secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spyre Therapeutics, Inc. (SYRE)
CIK:        0001636282
Form:       8-K
Filed at:   2022-02-10T23:59:59+00:00
Accession:  0001193125-22-033752
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Sara Brownstein resigns from Aeglea board citing disagreement over financing plans
--------------------------------------------------------------------------------

- Sara Brownstein resigned as Class I director effective February 9, 2022.
- Resignation attributed to disagreement regarding the Company's financing plans.
- No successor or interim director announced at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636282/000119312522033752/0001193125-22-033752-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636282/000119312522033752/d304706d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-033752

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer